Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
NetRegulus
company
About
NetRegulus Inc., a developer of software for the medical device industry.
- 5001 - 10000
Details
- Last Funding Type
- Debt Financing
- Industries
- Information Technology,Medical Device,Software
- Founded date
- Jan 1, 1982
- Number Of Employee
- 5001 - 10000
- Operating Status
- Active
NetRegulus is a global technology company that provides its users with IoT and AR platforms and enterprise applications. Its enterprise applications serve manufacturers and other businesses that create, connect, operate, analyze, and service products.NetRegulus was founded in 1982 and is based in Oak Brook, Illinois.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$7.20M
NetRegulus has raised a total of
$7.20M
in funding over 2 rounds. Their latest funding was raised on
Sep 30, 2006 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 30, 2006 | Debt Financing | — | 1 | — | — | Detail |
| Nov 15, 2005 | Series B | — | 1 | — | — | Detail |
| Mar 28, 2003 | Series B | $7.20M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
NetRegulus is funded by 2 investors.
Advantage Capital
and Garrett Capital/First Chicago
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Advantage Capital
|
— | Debt Financing |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
